Today in the Journal and on the Blog
 
 
 
 
 
HA Podcast: Coronavirus
The Latest Research, Commentary, and News from Health Affairs

Friday, March 13, 2020
Advertisement: Double executive masters in health policy with the London School of Economics and Political Science and the University of Chicago, apply now.
IN THE JOURNAL

AFFORDABLE CARE ACT

 By Julie Rovner

Julie Rovner discusses the challenges of covering the complex policies and politics of the Affordable Care Act.
Read More >>
TODAY ON THE BLOG

AFFORDABLE CARE ACT

 The following Health Affairs Blog posts are part of a short series, "The ACA at 10: Health Care Revolution," published with support from the Solomon Center for Health Law and Policy at Yale Law School and the Healthcare Transformation Institute at the University of Pennsylvania’s Perelman School of Medicine, Department of Medical Ethics & Health Policy.

The Affordable Care Act Made Health Care (Slightly) More Affordable
By Carrie Colla and Jonathan Skinner

In this post, we draw heavily on our recent contribution to a forthcoming volume, "The Trillion Dollar Experiment," to estimate the health care cost savings from the Affordable Care Act (ACA) over the past decade, and then examine the lessons of the ACA to better understand effective approaches for slowing the growth of health care spending. Read More >>


Evaluating The ACA’s Delivery System Reforms
By Ezekiel J. Emanuel, Amol S. Navathe, and Cathy Zhang

The Affordable Care Act included a number of types of delivery system reforms (DSRs), such as changing payments to health care providers and requiring greater reporting of quality and cost performance to the public. Most DSRs targeted uncoordinated or inefficient care under the traditional fee-for-service system. None of the programs has been a clear home run, but many have made major steps in the right direction. Read More >>


PHARMACEUTICALS AND MEDICAL TECHNOLOGY

Quality: The Often Overlooked Critical Element For Assuring Access To Safe And Effective Drugs
By Janet Woodcock and Michael Kopcha

Part of our preparation includes addressing key technical and regulatory issues ahead of time so as not to hinder promising technologies; we want to make sure the technologies are not only adopted but that they deliver on the promise of a higher level of manufacturing quality in the pharmaceutical industry.
Read More >>


CONSIDERING HEALTH SPENDING

Prices Are Not "Reimbursements"
By Shivani A. Shah and Michael E. Chernew

We should set prices (and methods of payment) to balance access and quality goals with budgetary concerns. Read More >>

A CLOSER LOOK—Drug Prices

The majority of Americans believe that lowering drug prices should be the top health care priority for the federal government. Yet drug costs as a proportion of the country’s medical expenditures have increased substantially in recent years. This Health Affairs article by Ezekiel J. Emanuel asks, "When Is The Price Of A Drug Unjust?"
Order A Copy of the March issue!
 
 
 
About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.  

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here.                                                                                          I